Inhibition of Candida albicans yeast-hyphal transition and biofilm formation by Solidago virgaurea water extracts

Journal of Medical Microbiology

Volumn 61, Issue PART7, 2012, Pages 1016-1022

  Chevalier, Marléne ^a   Medioni, Etienne ^a,b   Prêcheur, Isabelle ^a,b  

^a UNIVERSITÉ CÔTE D'AZUR   (France)

^b UNIVERSITY HOSPITAL OF NICE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DETERGENT; MOUTHWASH; PLANT EXTRACT; SAPONIN; SOLIDAGO VIRGAUREA EXTRACT; VIRULENCE FACTOR;

ARTICLE; BIOFILM; CANDIDA ALBICANS; CELL COUNT; CONTROLLED STUDY; CULTURE MEDIUM; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FUNGAL STRAIN; FUNGUS GROWTH; FUNGUS HYPHAE; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SOLIDAGO VIRGAUREA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS MUTANS; STREPTOCOCCUS SALIVARIUS; XEROSTOMIA;

ANTIFUNGAL AGENTS; BACTERIA; BIOFILMS; CANDIDA ALBICANS; HUMANS; HYPHAE; MICROBIAL SENSITIVITY TESTS; MICROSCOPY; PLANT EXTRACTS; SAPONINS; SOLIDAGO; TIME FACTORS;

EID: 84862662643     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.041699-0     Document Type: Article

References (30)

1. Alvarez, F. J., Douglas, L. M. & Konopka, J. B. (2007). Sterol-rich plasma membrane domains in fungi. Eukaryot Cell 6, 755-763.
2. Bader, G., Wray, V. & Hiller, K. (1995). The main saponins from the aerial parts and the roots of Solidago virgaurea subsp. virgaurea. Planta Med 61, 158-161.
3. Bahn, Y. S., Molenda, M., Staab, J. F., Lyman, C. A., Gordon, L. J. & Sundstrom, P. (2007). Genome-wide transcriptional profiling of the cyclic AMP-dependent signaling pathway during morphogenic transitions of Candida albicans. Eukaryot Cell 6, 2376-2390.
4. Blankenship, J. R. & Mitchell, A. P. (2006). How to build a biofilm: a fungal perspective. Curr Opin Microbiol 9, 588-594.
5. Chen, S. C., Playford, E. G. & Sorrell, T. C. (2010). Antifungal therapy in invasive fungal infections. Curr Opin Pharmacol 10, 522-530.
6. Coleman, J. J., Okoli, I., Tegos, G. P., Holson, E. B., Wagner, F. F., Hamblin, M. R. & Mylonakis, E. (2010). Characterization of plantderived saponin natural products against Candida albicans. ACS Chem Biol 5, 321-332.
7. Douglas, L. J. (2003). Candida biofilms and their role in infection. Trends Microbiol 11, 30-36.
8. Enjalbert, B. & Whiteway, M. (2005). Release from quorum-sensing molecules triggers hyphal formation during Candida albicans resumption of growth. Eukaryot Cell 4, 1203-1210.
9. García-Sánchez, S., Aubert, S., Iraqui, I., Janbon, G., Ghigo, J. M. & d'Enfert, C. (2004). Candida albicans biofilms: a developmental state associated with specific and stable gene expression patterns. Eukaryot Cell 3, 536-545.
10. Hameed, S., Prasad, T., Banerjee, D., Chandra, A., Mukhopadhyay, C. K., Goswami, S. K., Lattif, A. A., Chandra, J., Mukherjee, P. K. & other authors (2008). Iron deprivation induces EFG1-mediated hyphal development in Candida albicans without affecting biofilm formation. FEMS Yeast Res 8, 744-755.
11. Hawser, S. P., Norris, H., Jessup, C. J. & Ghannoum, M. A. (1998). Comparison of a 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino) carbonyl]-2H-tetrazolium hydroxide (XTT) colorimetric method with the standardized National Committee for Clinical Laboratory Standards method of testing clinical yeast isolates for susceptibility to antifungal agents. J Clin Microbiol 36, 1450-1452.
12. Hope, H., Bogliolo, S., Arkowitz, R. A. & Bassilana, M. (2008). Activation of Rac1 by the guanine nucleotide exchange factor Dck1 is required for invasive filamentous growth in the pathogen Candida albicans. Mol Biol Cell 19, 3638-3651.
13. Humphrey, S. P. & Williamson, R. T. (2001). A review of saliva: normal composition, flow, and function. J Prosthet Dent 85, 162-169.
14. Lamfon, H., Porter, S. R., McCullough, M. & Pratten, J. (2004). Susceptibility of Candida albicans biofilms grown in a constant depth film fermentor to chlorhexidine, fluconazole and miconazole: a longitudinal study. J Antimicrob Chemother 53, 383-385.
15. Martin, S. W. & Konopka, J. B. (2004). Lipid raft polarization contributes to hyphal growth in Candida albicans. Eukaryot Cell 3, 675-684.
16. Masuoka, J. (2004). Surface glycans of Candida albicans and other pathogenic fungi: physiological roles, clinical uses, and experimental challenges. Clin Microbiol Rev 17, 281-310.
17. Matsuda, H. (1999). Studies on chemical structures and pharmacological activities of triterpene saponins. Nat Med 53, 223-228.
18. Messier, C., Epifano, F., Genovese, S. & Grenier, D. (2011). Inhibition of Candida albicans biofilm formation and yeast-hyphal transition by 4-hydroxycordoin. Phytomedicine 18, 380-383.
19. Milgate, J. & Roberts, D. C. (1995). The nutritional and biological significance of saponins. Nutr Res 15, 1223-1249.
20. Nett, J. E., Cain, M. T., Crawford, K. & Andes, D. R. (2011). Optimizing a Candida biofilm microtiter plate model for measurement of antifungal susceptibility by tetrazolium salt assay. J Clin Microbiol 49, 1426-1433.
21. Nyilasi, I., Papp, T., Takó, M., Nagy, E. & Vágvölgyi, C. (2005). Iron gathering of opportunistic pathogenic fungi. A mini review. Acta Microbiol Immunol Hung 52, 185-197.
22. Oleszek, W. & Bialy, Y. (2006). Chromatographic determination of plant saponins - an update (2002-2005). J Chromatogr A 1112, 78-91.
23. Pesci-Bardon, C., Fosse, T., Serre, D. & Madinier, I. (2006). In vitro antiseptic properties of an ammonium compound combined with denture base acrylic resin. Gerodontology 23, 111-116.
24. Ramage, G., Vande Walle, K., Wickes, B. L. & López-Ribot, J. L. (2001). Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob Agents Chemother 45, 2475-2479.
25. Ramage, G., Jose, A., Coco, B., Rajendran, R., Rautemaa, R., Murray, C., Lappin, D. F. & Bagg, J. (2011). Commercial mouthwashes are more effective than azole antifungals against Candida albicans biofilms in vitro. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 111, 456-460.
26. Saville, S. P., Lazzell, A. L., Monteagudo, C. & Lopez-Ribot, J. L. (2003). Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection. Eukaryot Cell 2, 1053-1060.
27. ten Cate, J. M., Klis, F. M., Pereira-Cenci, T., Crielaard, W. & de Groot, P. W. (2009). Molecular and cellular mechanisms that lead to Candida biofilm formation. J Dent Res 88, 105-115.
28. Tyszkiewicz, E. W. (2008). Assessment report on Solidago Virgaurea L., herba. European Medicines Agency. Evaluation of medicines for human use. EMEA/HMPC, http://www.emea.europa.eu
29. Villar, C. C., Kashleva, H., Nobile, C. J., Mitchell, A. P. & Dongari- Bagtzoglou, A. (2007). Mucosal tissue invasion by Candida albicans is associated with E-cadherin degradation, mediated by transcription factor Rim101p and protease Sap5p. Infect Immun 75, 2126-2135.
30. Williams, D. & Lewis, M. (2011). Pathogenesis and treatment of oral candidosis. J Oral Microbiol 3, 5771.